Literature DB >> 19547907

Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure.

Andreas Link1, Jan Christian Reil, Simina Selejan, Michael Böhm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19547907     DOI： 10.1007/s00392-009-0038-9

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  10 in total

1.  Selective inhibition of the pacemaker channel I(f) improves symptoms in severe dilated cardiomyopathy.

Authors:  Uta C Hoppe; Karl La Rosée; Robert Larbig; Erland Erdmann
Journal:  Clin Res Cardiol       Date:  2007-02-26       Impact factor: 5.460

2.  Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure.

Authors:  Uri Elkayam; Gudaye Tasissa; Cynthia Binanay; Lynne W Stevenson; Mihai Gheorghiade; J Wayne Warnica; James B Young; Barry K Rayburn; Joseph G Rogers; Teresa DeMarco; Carl V Leier
Journal:  Am Heart J       Date:  2007-01       Impact factor: 4.749

3.  Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial.

Authors:  P Lechat; J S Hulot; S Escolano; A Mallet; A Leizorovicz; M Werhlen-Grandjean; G Pochmalicki; H Dargie
Journal:  Circulation       Date:  2001-03-13       Impact factor: 29.690

4.  Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial.

Authors:  Marco Metra; Christian Torp-Pedersen; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Michel Komajda; Willem J Remme; Beatrix Lutiger; Armin Scherhag; Mary Ann Lukas; Andrew Charlesworth; Philip A Poole-Wilson
Journal:  Eur Heart J       Date:  2005-07-21       Impact factor: 29.983

5.  Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.

Authors:  Jeffrey S Borer; Kim Fox; Patrice Jaillon; Guy Lerebours
Journal:  Circulation       Date:  2003-02-18       Impact factor: 29.690

6.  Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs.

Authors:  L Simon; B Ghaleh; L Puybasset; J F Giudicelli; A Berdeaux
Journal:  J Pharmacol Exp Ther       Date:  1995-11       Impact factor: 4.030

7.  Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study.

Authors:  Kim Fox; Roberto Ferrari; Michal Tendera; Philippe Gabriel Steg; Ian Ford
Journal:  Am Heart J       Date:  2006-11       Impact factor: 4.749

Review 8.  Inotropes in the management of acute heart failure.

Authors:  John W Petersen; G Michael Felker
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

Review 9.  The role of heart rate in the development of cardiovascular disease.

Authors:  J-C Reil; M Böhm
Journal:  Clin Res Cardiol       Date:  2007-06-27       Impact factor: 5.460

10.  Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure.

Authors:  Gaetano M De Ferrari; Antonio Mazzuero; Laura Agnesina; Alessandra Bertoletti; Maddalena Lettino; Carlo Campana; Peter J Schwartz; Luigi Tavazzi
Journal:  Eur J Heart Fail       Date:  2008-05-16       Impact factor: 15.534
  10 in total
  14 in total

1.  Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice.

Authors:  Ralf Koester; Jan Kaehler; Henning Ebelt; Gerold Soeffker; Karl Werdan; Thomas Meinertz
Journal:  Clin Res Cardiol       Date:  2010-05-09       Impact factor: 5.460

2.  Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study.

Authors:  Robert S Hoke; Ursula Müller-Werdan; Christine Lautenschläger; Karl Werdan; Henning Ebelt
Journal:  Clin Res Cardiol       Date:  2011-11-03       Impact factor: 5.460

3.  Use of ivabradine in catecholamine-induced tachycardia after high-risk cardiac surgery.

Authors:  Domenico Vitale; Vincenzo De Santis; Fabio Guarracino; Andrea Fontana; Fabio Pellegrini; Luigi Tritapepe
Journal:  Clin Res Cardiol       Date:  2010-09-07       Impact factor: 5.460

4.  Diagnostic accuracy of NT-proBNP ratio (BNP-R) for early diagnosis of tachycardia-mediated cardiomyopathy: a pilot study.

Authors:  Amir M Nia; Natig Gassanov; Kristina M Dahlem; Evren Caglayan; Martin Hellmich; Erland Erdmann; Fikret Er
Journal:  Clin Res Cardiol       Date:  2011-05-03       Impact factor: 5.460

5.  Lasting reduction of heart transplant tachycardia with ivabradine is effective and well tolerated: results of 48-month study.

Authors:  Ruoyu Zhang; Dmitry Bobylev; Penelope Stiefel; Axel Haverich; Christoph Bara
Journal:  Clin Res Cardiol       Date:  2012-03-04       Impact factor: 5.460

6.  [Heart rate and rate control : Prognostic value in cardiovascular diseases].

Authors:  F Custodis; J-C Reil; U Laufs; M Böhm
Journal:  Internist (Berl)       Date:  2012-01       Impact factor: 0.743

Review 7.  Heart rate reduction in cardiovascular disease and therapy.

Authors:  Jan-Christian Reil; Florian Custodis; Karl Swedberg; Michel Komajda; Jeffrey S Borer; Ian Ford; Luigi Tavazzi; Ulrich Laufs; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2010-09-01       Impact factor: 5.460

Review 8.  Ivabradine: potential clinical applications in critically ill patients.

Authors:  Vincenzo De Santis; Domenico Vitale; Anna Santoro; Aurora Magliocca; Andrea Giuseppe Porto; Cecilia Nencini; Luigi Tritapepe
Journal:  Clin Res Cardiol       Date:  2012-10-14       Impact factor: 5.460

9.  Pathophysiologic Insights into Heart Rate Reduction in Heart Failure: Implications in the Use of Beta-Blockers and Ivabradine.

Authors:  Takeshi Kitai; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02

10.  Adjuvant Use of Ivabradine in Acute Heart Failure due to Myocarditis.

Authors:  Jennifer Franke; Dorothee Schmahl; Stephanie Lehrke; Regina Pribe; Raffi Bekeredjian; Andreas O Doesch; Philipp Ehlermann; Philipp Schnabel; Hugo A Katus; Christian Zugck
Journal:  Case Rep Med       Date:  2011-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.